Craig-Hallum Initiates Coverage On TELA Bio with Buy Rating, Announces Price Target of $2

9/25/2026
Impact: 70
Healthcare

Craig-Hallum analyst Chase Knickerbocker has initiated coverage on TELA Bio (NASDAQ: TELA) with a Buy rating. The analyst has set a price target of $2 for the company's stock.

AI summary, not financial advice

Share: